ProKidney Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PROK research report →
Companywww.prokidney.com
ProKidney Corp. , a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract.
- CEO
- Bruce Culleton
- IPO
- 2021
- Employees
- 204
- HQ
- Winston-Salem, NC, US
Price Chart
Valuation
- Market Cap
- $544.57M
- P/E
- -3.21
- P/S
- 1390.18
- P/B
- -0.23
- EV/EBITDA
- -7.31
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -224.41%
- Op Margin
- -18959.73%
- Net Margin
- -8418.00%
- ROE
- 7.40%
- ROIC
- -54.77%
Growth & Income
- Revenue
- $893.00K · 1075.00%
- Net Income
- $-68,986,000 · -12.75%
- EPS
- $-0.52 · 16.13%
- Op Income
- $-165,007,000
- FCF YoY
- 13.18%
Performance & Tape
- 52W High
- $7.13
- 52W Low
- $0.54
- 50D MA
- $1.92
- 200D MA
- $2.32
- Beta
- 1.75
- Avg Volume
- 847.36K
Get TickerSpark's AI analysis on PROK
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 28, 26 | Control Empresarial de Capitales S.A. de C.V. | other | 63,118,645 |
| Apr 28, 26 | Control Empresarial de Capitales S.A. de C.V. | other | 63,118,645 |
| Apr 28, 26 | Control Empresarial de Capitales S.A. de C.V. | other | 63,118,645 |
| Mar 1, 26 | Coulston James | other | 600,000 |
| Mar 1, 26 | Weber Darin J. | other | 400,000 |
| Mar 1, 26 | Girolamo Todd C | other | 600,000 |
| Mar 1, 26 | Culleton Bruce | other | 3,000,000 |
| Nov 12, 25 | Pereira Brian JG | sell | 227,431 |
| Nov 12, 25 | Pereira Brian JG | sell | 27,595 |
| Nov 13, 25 | Pereira Brian JG | sell | 54,333 |
Our PROK Coverage
We haven't published any research on PROK yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PROK Report →